𝔖 Bobbio Scriptorium

✦ LIBER ✦

92 In vitro isolation of bicyclam-resistant variants of human immunodeficiency virus type 1: M. Baba,1 N. Yamamoto,2 R. Pauwels,2 Z. Debyser,2 S. Shigeta,1 E. De Clercq,2 G. Bridger,3 G. Henson,3 and M. Abrams3 1Department of Microbiology, Fukushima Medical College, Fukushima 960-12, Japan, 2Rega Institute, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and 3Johnson Matthey Pharmaceutical Research, Pennsylvania 19380, U.S.A.

Book ID: 118393161
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 72 KB
Volume: 20
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(93)90470-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3 Highly selective and potent inhibition

3 Highly selective and potent inhibition of human immunodeficiency virus (HIV) by the novel bicyclam derivative JM31000: E. De Clercq1, N. Yamamoto1, R. Pauwels1, M. Witvrouw1, K. De Vreese1, Z. Debyser1, R. Skerlj3, D. Thornton2, G. Bridger3, G. Henson3 and M. Abrams3 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; and 3Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

139 MKC-442, a highly potent and specifi

139 MKC-442, a highly potent and specific inhibitor of HIV-1: M. Baba,1 S. Shigeta,1 S. Yuasa,2 M. Ubasawa,2 H. Tanaka,3 T. Miyasaka,3 R.T. Walker,4 and E. De Clercq5 Department of Microbiology, Fukushima Medical College, Fukushima 960-12,1 Mitsubishi Kasei Corporation Research Center, Yokohama 227,2 Department of Synthetic Chemistry, Showa University, Tokyo 142,3 Japan; University of Birmingham, Birmingham B15 2TT, Great Britain4; and Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium5

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 81 KB

30 Potent inhibition of human immunodefi

30 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of macrocyclic ring size: S. Padmanabhan1, G. Bridger1, R. Skerlj1, D. Thornton2, M. Abrams1, G. Henson1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 66 KB

32 Potent inhibition of human immunodefi

32 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Structure activity relationships: G. Bridger1, R. Skerlj1, S. Padmanabhan1, D. Thomton2, G. Henson1, M. Abrams1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Potent and selective inhibition of HIV-1

Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating : E. De Clercq, N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, Z. Debyser, B.A. Murrer, D. Schwartz, D. Thornton, G. Bridger, S. Fricker, G. Henson, M. Abrams and D. Picker Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, Great Britain, and Johnson Matthey Pharmaceutical Research, West Chester, PA 19380, U.S.A.

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 72 KB

200 In vitro activity of a novel series

200 In vitro activity of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses: S. Ikeda1, J. Neyts1, N. Yamamoto1, B. Murrer2, B. Theobald2, G. Bossard3, G. Henson3, M. Abrams3, D. Picker3 and E. De Clercq1 1Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium, 2Johnson Matthey, Technology Centre, Blount's Court, Sonning Common, Reading RG4 9NH, Great Britain, 3Johnson Matthey Pharmaceutical Research, 1401 King Road, West Chester, Pa 19380, U.S.A.

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB